Part B ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	3

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01211249 (ClinicalTrials.gov)	October 2010	28/9/2010	GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis	Randomized, Double-Blind, Placebo-Controlled, Multicenter, Exploratory Phase II Study to Compare Thr ...	Rheumatoid Arthritis	Drug: GLPG0259 oral capsule;Drug: Placebo;Drug: GLPG0259 (Part B);Drug: Placebo (Part B)	Galapagos NV	NULL	Completed	18 Years	70 Years	Both	30	Phase 2	Belgium;Netherlands;Poland;Russian Federation;Ukraine
2	EUCTR2005-003495-38-GR (EUCTR)	27/02/2006	30/06/2006	Part A: A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of ...	Part A: A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of ...	Rheumatoid Arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: P38 (4) Map Kinase Inhibitor Product Code: RO4402257 Other descriptive name: P38(4) Map ...	F. Hoffmann-La Roche Ltd	NULL	Not Recruiting			Female: yes Male: yes	440	Phase 2	Estonia;Greece;Spain;Ireland;Germany;United Kingdom
3	NCT00291928 (ClinicalTrials.gov)	February 2005	14/2/2006	HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II	A Double-blind, Randomized, Placebo Controlled, Dose Escalation, Multi-centerphase I/II Trial of HuM ...	Arthritis, Rheumatoid	Drug: Part A;Drug: Part B	GlaxoSmithKline	NULL	Completed	18 Years	N/A	Both	201	Phase 2	United States;Denmark;Finland;France;Hungary;Poland;United Kingdom

First Previous1Next Last